Epigenetics of hypertension as a risk factor for the development of coronary artery disease in type 2 diabetes mellitus

被引:3
|
作者
Karabaeva, Raushan Zh [1 ]
Vochshenkova, Tamara A. [1 ]
Mussin, Nadiar M. [2 ]
Albayev, Rustam K. [1 ]
Kaliyev, Asset A. [2 ]
Tamadon, Amin [3 ,4 ]
机构
[1] Presidents Affairs Adm Republ Kazakhstan, Med Ctr Hosp, Gerontol Ctr, Astana, Kazakhstan
[2] West Kazakhstan Marat Ospanov Med Univ, Gen Surg, Aktobe, Kazakhstan
[3] West Kazakhstan Marat Ospanov Med Univ, Dept Nat Sci, Aktobe, Kazakhstan
[4] PerciaVista R&D Co, Dept Res & Dev, Shiraz, Iran
来源
关键词
coronary artery disease; hypertension; type 2 diabetes mellitus; epigenetics; genetic variation; DNA methylation; histone; modification; DNA METHYLATION; BLOOD-PRESSURE; CARDIAC-HYPERTROPHY; LIFE-STYLE; GENE; MODULATION; EXPRESSION; SALT; PREECLAMPSIA; DEFICIENCY;
D O I
10.3389/fendo.2024.1365738
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension, a multifaceted cardiovascular disorder influenced by genetic, epigenetic, and environmental factors, poses a significant risk for the development of coronary artery disease (CAD) in individuals with type 2 diabetes mellitus (T2DM). Epigenetic alterations, particularly in histone modifications, DNA methylation, and microRNAs, play a pivotal role in unraveling the complex molecular underpinnings of blood pressure regulation. This review emphasizes the crucial interplay between epigenetic attributes and hypertension, shedding light on the prominence of DNA methylation, both globally and at the gene-specific level, in essential hypertension. Additionally, histone modifications, including acetylation and methylation, emerge as essential epigenetic markers linked to hypertension. Furthermore, microRNAs exert regulatory influence on blood pressure homeostasis, targeting key genes within the aldosterone and renin-angiotensin pathways. Understanding the intricate crosstalk between genetics and epigenetics in hypertension is particularly pertinent in the context of its interaction with T2DM, where hypertension serves as a notable risk factor for the development of CAD. These findings not only contribute to the comprehensive elucidation of essential hypertension but also offer promising avenues for innovative strategies in the prevention and treatment of cardiovascular complications, especially in the context of T2DM.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Silent coronary artery disease in patients with type 2 diabetes mellitus
    A. Gokcel
    M. Aydin
    F. Yalcin
    A. F. Yapar
    M. E. Ertorer
    A. K. Ozsahin
    H. Muderrisoglu
    A. Aktas
    N. Guvener
    M. Akbaba
    Acta Diabetologica, 2003, 40 : 176 - 180
  • [32] Management of coronary artery disease in patients with type 2 diabetes mellitus
    Srikanth S.
    Deedwania P.
    Current Cardiology Reports, 2007, 9 (4) : 264 - 271
  • [33] Diffuse atherosclerosis in type 2 diabetes mellitus with coronary artery disease
    Watanabe, Y
    Nakagawa, S
    Hirotani, T
    Atsumi, Y
    Kameda, T
    Matsuoka, K
    DIABETES, 2000, 49 : A151 - A151
  • [34] Apparent therapy-resistant hypertension as risk factor for the development of type 2 diabetes mellitus
    Holtrop, Joris
    Spiering, Wilko
    Nathoe, Hendrik M.
    De Borst, Gert J.
    Kappelle, Laurens J.
    De Valk, Harold W.
    Visseren, Frank L. J.
    Westerink, Jan
    JOURNAL OF HYPERTENSION, 2020, 38 (01) : 45 - 51
  • [35] Coronary Ostial Level of Adiponectin as a Risk Factor for Coronary Artery Disease in Patients with Diabetes Mellitus
    El-Menyar, Ayman
    Rizk, Nasser
    Alnabti, Abdulrahman
    Al Suwaidi, Jassim
    CIRCULATION, 2010, 122 (02) : E251 - E251
  • [36] Is Prehypertension a Risk Factor for the Development of Type 2 Diabetes Mellitus?
    Mullican, David
    Lorenzo, Carlos
    Stern, Michael P.
    Haffner, Steven M.
    DIABETES, 2009, 58 : A65 - A65
  • [37] Hypoglycemia in Diabetes Mellitus as a Coronary Artery Disease Risk Factor in Patients at Elevated Vascular Risk
    Leong, Aaron
    Berkowitz, Seth A.
    Triant, Virginia A.
    Porneala, Bianca
    He, Wei
    Atlas, Steven J.
    Wexler, Deborah J.
    Meigs, James B.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (02): : 659 - 668
  • [38] The patient with hypertension -: is there a fivefold risk for the development of Type 2 diabetes mellitus
    Maros, Z
    Csötönyi, G
    Füzi, M
    Hancsicsák, J
    Simek, A
    Nyirati, G
    Kempler, P
    DIABETOLOGIA, 2002, 45 : A102 - A103
  • [39] An atherogenic midband lipoprotein: a risk factor for coronary artery disease in diabetes mellitus with hyperlipidemia
    Kawano, M
    Shinomiya, M
    Kanzaki, T
    Morisaki, N
    Shirai, K
    Saito, Y
    Yoshida, S
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1998, 41 (01) : 45 - 48
  • [40] Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus
    Oe, Momoko
    Fujihara, Kazuya
    Yamada, Mayuko Harada
    Osawa, Taeko
    Kitazawa, Masaru
    Matsubayashi, Yasuhiro
    Sato, Takaaki
    Yaguchi, Yuta
    Iwanaga, Midori
    Yamada, Takaho
    Sone, Hirohito
    JOURNAL OF DIABETES INVESTIGATION, 2024, 15 (10) : 1464 - 1471